Avai Bio (AVAI) Other Operating Expenses (2018 - 2026)

Avai Bio (AVAI) has 9 years of Other Operating Expenses data on file, last reported at -$95271.0 in Q1 2026.

• For the quarter ending Q1 2026, Other Operating Expenses fell 169.77% year-over-year to -$95271.0; the trailing twelve-month figure through Mar 2026 stood at $603927.0 (down 21.31% YoY), and the FY2026 full-year result was $672926.0, down 12.55% from the prior year.
• Other Operating Expenses retreated to -$95271.0 in Q1 2026, from $319655.0 in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $603084.0 in Q1 2024 to a low of -$95271.0 in Q1 2026.
• A 5-year average of $129804.4 and a median of $77768.0 in 2023 frame the typical range for Other Operating Expenses.
• Across the five-year window, Other Operating Expenses surged 1668.49% in 2024 and plunged 169.77% in 2026, its largest moves.
• Tracing AVAI's Other Operating Expenses over 5 years: stood at $10783.0 in 2022, then soared by 159.36% to $27967.0 in 2023, then surged by 503.56% to $168797.0 in 2024, then surged by 89.37% to $319655.0 in 2025, then sank by 129.8% to -$95271.0 in 2026.
• Business Quant data shows AVAI's Other Operating Expenses at -$95271.0 in Q1 2026, $319655.0 in Q4 2025, and $105840.0 in Q3 2025.